University of Pittsburgh
Pittsburgh, Pennsylvania, 15261, United States
NCT Number: NCT04496076
A prospective cohort minimal risk study to determine the impact of the COVID-19 crisis on outcomes of neurologically injured ICU patients.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Pittsburgh, Pennsylvania, 15261, United States
COVID 19 pandemic has overwhelmed healthcare capacity in many regions around the world. As resources become more limited and we have to triage /ration ventilators, neurologically injured ICU patients without COVID 19 but with respiratory insufficiency may be triaged to no ventilator care due to their perceived or actual prognosis. This may lead to increased rates of withdrawal of care and mortality. Some neurologically injured ICU patients with respiratory insufficiency may be simultaneously infected with COVID 19. Their outcomes are completely unknown. Capturing data on the prevalence of limitation of care and prognosis in this patient population will provide important information towards ongoing efforts in patient care and resource utilization as we face the rapidly evolving COVID 19 pandemic. Given the expected strain on ICU resources and limitations in research in ICUs during COVID 19 pandemic, data capture/study design must be targeted and pragmatic. This study is designed to answer the most basic and important questions while minimizing the burden of data collection on already overloaded providers.
This study design is comprised of two components: Component 1- Prospective cohort prevalence study captures data related to treatments offered, limitations of care and patient outcome in 5 select primary neurological diagnoses requiring ICU care. Component 2- Case control study captures the same data elements in the same patient populations during the 3 months prior COVID 19 pandemic (Sept - Dec, 2019).
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: At hospital discharge, approximately 1 month
Time frame: 30 days post-hospital discharge
Time frame: During In-hospital course, up to 1 month
Care treatment such as ventilator use, intubation, and/or tracheostomy
Time frame: During In-hospital course, up to 1 month
University of Pittsburgh
Other
Severe Neurologic Injury Outcomes During COVID-19 Crisis
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04353609
Autoimmune Diseases, COVID-19
Lille, France
View Trial DetailsNCT04356495
Corona Virus Infection, Coronaviridae Infections
Bordeaux, France
View Trial DetailsNCT04378842
COVID-19, Coronaviridae Infections
Amiens, France
View Trial DetailsNCT04393974
Cancer, Neoplasms
Brussels, Belgium
View Trial Details